TruSpine #TSP August 2023 – CEO Laurence Strauss talks to Alan Green

Alan Green talks to Truspine #TSP CEO Laurence Strauss about the developments year to date, and the Company’s recent 510k submission to the US FDA for approval of the Cervi-LOK spinal stabilisation system. Laurence outlines his plans for a US trip to meet with the IP lawyers and the equipment distributors before we discuss the […]

Quoted Micro 31 July 2023

AQUIS STOCK EXCHANGE Oberon Investments (OBE) reported a decline from £6.7m to £5m because of lower share dealing and capital markets income. The loss increased from £581,000 to £3.9m, which was predominantly down to one-off reorganisation and transaction costs. Management is confident that acquisitions and new teams will enable revenues to grow to more than […]

TruSpine #TSP transition – CEO Laurence Strauss talks to Alan Green

Aquis Exchange listed Truspine Technologies #TSP is both owner and developer of three uniquely disruptive technologies to revolutionise the spinal stabilisation market. These pioneering spinal devices, namely Cervi-LOK™ (for the cervical and upper thoracic spine), GRASP Laminoplasty (a treatment for decompression of the spinal cord) & Faci-LOK™ (for the lumbar and lower thoracic spine) are […]

Andrew Hore – Quoted Micro 31 May 2021

AQUIS STOCK EXCHANGE Pharma C Investments (PCIL) is a shell seeking to invest in medicinal cannabis sector-focused companies, particularly those that provide ancillary products and services to the sector, and it joined the Access segment on 26 May. The indication is that plant genetics, product testing, marketing, procurement services and cannabis consumption devices are areas […]